| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |